17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F1α
Shipping is calculated in checkout
1027401-98-4
≥98%
A solution in methyl acetate
C24H35F3O5
460.5
9α,11α,15s-trihydroxy-17-trifluoromethylphenyl-18,19,20-trinor-prostan-1-oic acid, 17-tfm-pgf1α
- Data sheet: View or download
- MSDS: View or download
A number of 17-aryl trinor and 16-aryloxy tetranor PGF2α derivatives have been approved for the treatment of glaucoma.{8941,9341,8839} These “ring” prostaglandin analogs have improved efficacy over the prostaglandins with an n-alkyl lower side chain. Of these, the ones wherein the 13,14-double bond has been hydrogenated retain relatively good potency, but show a significantly reduced incidence of local irritant side effects.{9736} 17-TFM-PGF1α is a typical “ring” analog reminiscent of the trifluoromethyl-phenoxy ring of Travoprost. The a chain of 17-TFM-PGF1α is saturated, making this compound a formal member of the one-series PGs. Recent work has shown that in the “ring” series of analogs, this modification has little impact on FP receptor binding.{9668} As an ocular hypotensive agent, it is expected that 17-TFM-PGF1α would act very much like the free acid of latanoprost.
